Abstract:Cardiac surgery is associated with hyperglycemia, which in turn is associated with adverse post-surgical outcomes such as wound infections, acute renal failure, and mortality. This pilot study seeks to determine if Dexcom G6Pro continuous glucose monitor (Dexcom G6Pro CGM) is accurate during the postoperative cardiac surgery period when fluid shifts, systemic inflammatory response syndrome (SIRS), and vasoactive medications are frequently encountered, compared to standard glucose monitoring techniques. Methods This study received IRB approval. In this prospective study, correlation between clinical and Dexcom glucose readings was evaluated. Clinical glucose (blood gas, metabolic panel, and point of care [POC]) dataset included 1428 readings from 29 patients, while the Dexcom G6Pro CGM data included 45,645 data points following placement to upper arm. Additionally, average clinical measurements of day and overnight temperatures and hemodynamics were evaluated. Clinical and Dexcom data were restricted to being at least 1 hour after prior clinical reading Matching Dexcom G6Pro CGM data were required within 5 minutes of clinical measure. Data included only if taken at least 2 hours after Dexcom G6Pro CGM insertion (warm-up time) and and analyzed only following ICU admission. Finally, a dataset excluding the first 24 hours after ICU admission was created to explore stability of the device. Patients remained on Dexcom G6Pro CGM until discharge or 10 days postoperatively. Results The population was 71% male, 14% with known diabetes; 66% required IV insulin infusion. The Clarke error grid plot of all measures post-ICU admission showed 53.5% in Zone A, 45.9% in Zone B, and 0.6% (n=5) in Zones D or E. The restricted dataset that excluded the first 24 hours post-ICU admission showed 55.9% in Zone A, 43.9% in Zone B, and 0.2% in Zone D. Mean absolute relative difference (MARD) between clinical and Dexcom G6Pro CGM measures was 20.6% and 21.6% in the entire post-ICU admission dataset, and the dataset excluding the first 24 hours after ICU admission, respectively. In the sub-analysis of the 12 patients who did not have more than a 5-minute tap in the operating room, a Consensus error grid, demonstrated that after ICU admission, percentage in zone A was 53.9%, zone B 45.4%, and zone C 0.7%. Similar percentages were obtained removing the first 24 hours post-ICU admission. These numbers are very similar to the entire cohort. A consensus error grid created post-ICU admission demonstrated: (Zone A) 54%, (Zone B) 45%, (Zone C) 0.9%, and the following for the dataset created excluding the first 24 hours: (Zone A) 56%, (Zone B) 44%, (Zone C) 0.4%, which demonstrated very close agreement with the original Clarke error grid. No adverse events were reported. Conclusions Almost 100% of Dexcom G6Pro CGM and clinical data matching points fell within areas considered as giving clinically correct decisions (Zone A) and clinically uncritical decisions (Zone B). However, the relatively high MARD precludes its use for both monitoring and treatment in the clinical context. As technology evolves, interstitial glucose monitoring may become an important tool to limit iatrogenic anemia and mitigate glycemic fluctuations.

Continuous monitoring after laparoscopic Roux-En-Y gastric bypass: a pathway to ambulatory care surgery – a pilot study

Monitoring of home recovery using the 317-nursing mobile application following day-case surgery in children: Perspectives from both nurses and patients.

Feasibility of remote digital monitoring using wireless Bluetooth monitors, the Smart Angel™ app and an original web platform for patients following outpatient surgery: a prospective observational pilot study

Reliability of continuous vital sign monitoring in post-operative patients employing consumer-grade fitness trackers: A randomised pilot trial

Improving diagnosis of early complications (<1 week) through continuous vital sign monitoring following oncological gastrointestinal surgical procedures

Perioperative non-invasive versus semi-invasive cardiac index monitoring in patients with bariatric surgery - a prospective observational study

Wireless wearables for postoperative surveillance on surgical wards: a survey of 1158 anaesthesiologists in Western Europe and the USA

Feasibility of continuous non-invasive delivery of oxygen monitoring in cardiac surgical patients: a proof-of-concept preliminary study

Introducing intravascular microdialysis for continuous lactate monitoring in patients undergoing cardiac surgery: a prospective observational study

Impact of wearable wireless continuous vital sign monitoring in abdominal surgical patients: before–after study

Remote monitoring after elective colorectal surgery, a pilot study

Surveillance of high-risk early postsurgical patients for real-time detection of complications using wireless monitoring (SHEPHERD study): results of a randomized multicenter stepped wedge cluster trial

Wireless Continuous Arterial Blood Pressure Monitoring During Surgery: A Pilot Study

Accuracy and role of consumer facing wearable technology for continuous monitoring during endoscopic procedures

Feasibility of Same-Day Discharge After Laparoscopic Roux-en-Y Gastric Bypass in Patients with Well-Regulated Obstructive Sleep Apnea

Intraoperative Patterns of Gastric Microperfusion During Laparoscopic Sleeve Gastrectomy

Continuous Glucose Monitoring Using the Dexcom G6 in Cardiac Surgery during the Postoperative Period.

Enhancing cardiac postoperative care: a smartwatch-integrated remote telemonitoring platform for health screening with ECG analysis

Peri-anastomotic microdialysis lactate assessment after esophagectomy

Evaluation of remote digital postoperative wound monitoring in routine surgical practice

Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation